Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Administration of trial drugs Strozagel, Nuravon sans licensing authority nod: Forum absolves Apollo Group affiliate hospital, 3 doctors of medical negligence charges

Farhat Nasim11 Dec 2022 6:45 PM IST

Ranchi: The National Consumer Disputes Redressal Commission (NCDRC) has absolved a hospital affiliated to leading Apollo Group of hospitals, a...

No relief for 16 students admitted without NEET MDS qualification, HC slaps Rs 25 lakh fine on Dental College

Farhat Nasim11 Dec 2022 2:00 PM IST

Jaipur: Noting that backdoor entries in educational institutions should be stopped and discouraged, the Rajasthan High Court has directed Daswani...

Fortis to onboard new 550-bed super specialty hospital in Lucknow

Bacterial infection post knee replacement surgery: NCDRC absolves Orthopaedician, Fortis Hospital, dismisses Rs 1 crore compensation case

Farhat Nasim10 Dec 2022 5:24 PM IST

Noida: An Orthopedic Surgeon associated with Fortis Hospital Noida has been absolved of charges of medical negligence during the Total Knee...

NMC Gives Conditional Approval to 36 GMCs in Tamil Nadu

Ahmedabad Medical College to be renamed Narendra Modi Medical college

Farhat Nasim8 Dec 2022 3:31 PM IST

Ahmedabad: The National Medical Commission (NMC) on Tuesday has given its approval for change in the name of Ahmedabad Municipal Corporation Medical...

HC Denies Relief to NEET PG Candidate Seeking to Change From General To OBC Category After Declaration Of Results

HC upholds 30 percent cap on trade margin of 42 anti-cancer drugs

Farhat Nasim6 Dec 2022 10:30 AM IST

New Delhi: Observing that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to...

Alleged medical negligence in Bariatric Surgery: Forum exonerates Chennai Hospital, doctor, dismisses Rs 6 crore compensation case

Farhat Nasim4 Dec 2022 5:26 PM IST

Chennai: The National Consumer Disputes Redressal Commission (NCDRC) has exonerated a doctor and a Chennai hospital from charges of medical negligence...

Max Healthcare outweighs Manipal's AMRI bid by Rs 900 crore in takeover tussle: Report

Farhat Nasim3 Dec 2022 2:00 PM IST

New Delhi: Sparking a potential full-blown corporate tussle between two of India's leading hospital chains, Max Healthcare Institute is eyeing the...

No bar on taking corrective measures if error occurs in fixing retail price of drugs: NPPA

Farhat Nasim28 Nov 2022 6:00 PM IST

New Delhi: There can be no bar on National Pharmaceutical Pricing Authority (NPPA) to take corrective measures if it finds out some inconsistency or...

Patient dies from suspected drug reaction to Emcure Pharma's Orofer FCM, Maha FDA issues nationwide recall

Farhat Nasim24 Nov 2022 5:48 PM IST

Pune: Drug maker Emcure Pharmaceuticals Ltd. has landed in trouble after a patient at Saifee Hospital administered iron supplement, Orofer FCM (ferric...

Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order

Farhat Nasim24 Nov 2022 12:24 PM IST

New Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous...

Game-Changer for HIV: Dr Reddys, Hetero to Sell Generic Lenacapavir at Rs 3,547 a Year

Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report

Farhat Nasim22 Nov 2022 6:36 PM IST

New Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...

Union Health Ministry notifies 300 drug brands under Schedule H2, Details

Farhat Nasim21 Nov 2022 5:38 PM IST

New Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok